Illumina Body Map 2
Gene Symbol | Gene ID | Gene Info |
---|---|---|
HIC1
|
ENSG00000177374.8 | HIC ZBTB transcriptional repressor 1 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
HIC1 | hg19_v2_chr17_+_1958388_1958404 | -0.05 | 7.8e-01 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chrX_-_153151586 | 5.66 |
ENST00000370060.1
ENST00000370055.1 ENST00000420165.1 |
L1CAM
|
L1 cell adhesion molecule |
chr14_-_94254821 | 5.15 |
ENST00000393140.1
|
PRIMA1
|
proline rich membrane anchor 1 |
chr7_+_70597109 | 4.87 |
ENST00000333538.5
|
WBSCR17
|
Williams-Beuren syndrome chromosome region 17 |
chr9_-_112083229 | 4.46 |
ENST00000374566.3
ENST00000374557.4 |
EPB41L4B
|
erythrocyte membrane protein band 4.1 like 4B |
chr11_-_2160611 | 4.33 |
ENST00000416167.2
|
IGF2
|
insulin-like growth factor 2 (somatomedin A) |
chr13_+_98795664 | 4.32 |
ENST00000376581.5
|
FARP1
|
FERM, RhoGEF (ARHGEF) and pleckstrin domain protein 1 (chondrocyte-derived) |
chr14_+_33408449 | 4.30 |
ENST00000346562.2
ENST00000341321.4 ENST00000548645.1 ENST00000356141.4 ENST00000357798.5 |
NPAS3
|
neuronal PAS domain protein 3 |
chr19_+_709101 | 4.25 |
ENST00000338448.5
|
PALM
|
paralemmin |
chr1_+_18434240 | 4.19 |
ENST00000251296.1
|
IGSF21
|
immunoglobin superfamily, member 21 |
chr11_+_101981423 | 4.07 |
ENST00000531439.1
|
YAP1
|
Yes-associated protein 1 |
chr12_+_121078355 | 3.99 |
ENST00000316803.3
|
CABP1
|
calcium binding protein 1 |
chr19_+_708910 | 3.97 |
ENST00000264560.7
|
PALM
|
paralemmin |
chr2_-_10220538 | 3.93 |
ENST00000381813.4
|
CYS1
|
cystin 1 |
chr5_+_6448736 | 3.86 |
ENST00000399816.3
|
UBE2QL1
|
ubiquitin-conjugating enzyme E2Q family-like 1 |
chr6_+_56819773 | 3.85 |
ENST00000370750.2
|
BEND6
|
BEN domain containing 6 |
chr7_+_73082152 | 3.76 |
ENST00000324941.4
ENST00000451519.1 |
VPS37D
|
vacuolar protein sorting 37 homolog D (S. cerevisiae) |
chr12_-_132905789 | 3.69 |
ENST00000328957.8
|
GALNT9
|
UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 9 (GalNAc-T9) |
chr11_-_61348576 | 3.67 |
ENST00000263846.4
|
SYT7
|
synaptotagmin VII |
chr13_+_98795505 | 3.64 |
ENST00000319562.6
|
FARP1
|
FERM, RhoGEF (ARHGEF) and pleckstrin domain protein 1 (chondrocyte-derived) |
chr19_-_460996 | 3.54 |
ENST00000264554.6
|
SHC2
|
SHC (Src homology 2 domain containing) transforming protein 2 |
chr4_+_3768075 | 3.52 |
ENST00000509482.1
ENST00000330055.5 |
ADRA2C
|
adrenoceptor alpha 2C |
chr3_+_39851094 | 3.47 |
ENST00000302541.6
|
MYRIP
|
myosin VIIA and Rab interacting protein |
chr22_+_48972118 | 3.38 |
ENST00000358295.5
|
FAM19A5
|
family with sequence similarity 19 (chemokine (C-C motif)-like), member A5 |
chr19_-_18717627 | 3.37 |
ENST00000392386.3
|
CRLF1
|
cytokine receptor-like factor 1 |
chr4_-_109684120 | 3.36 |
ENST00000512646.1
ENST00000411864.2 ENST00000296486.3 ENST00000510706.1 |
ETNPPL
|
ethanolamine-phosphate phospho-lyase |
chr18_+_33877654 | 3.32 |
ENST00000257209.4
ENST00000445677.1 ENST00000590592.1 ENST00000359247.4 |
FHOD3
|
formin homology 2 domain containing 3 |
chr13_-_110959478 | 3.29 |
ENST00000543140.1
ENST00000375820.4 |
COL4A1
|
collagen, type IV, alpha 1 |
chr1_+_6845384 | 3.29 |
ENST00000303635.7
|
CAMTA1
|
calmodulin binding transcription activator 1 |
chr4_+_1795012 | 3.20 |
ENST00000481110.2
ENST00000340107.4 ENST00000440486.2 ENST00000412135.2 |
FGFR3
|
fibroblast growth factor receptor 3 |
chr22_+_33197683 | 3.16 |
ENST00000266085.6
|
TIMP3
|
TIMP metallopeptidase inhibitor 3 |
chr13_+_110959598 | 3.15 |
ENST00000360467.5
|
COL4A2
|
collagen, type IV, alpha 2 |
chr6_+_56820018 | 3.12 |
ENST00000370746.3
|
BEND6
|
BEN domain containing 6 |
chr10_-_125651258 | 3.04 |
ENST00000241305.3
|
CPXM2
|
carboxypeptidase X (M14 family), member 2 |
chr11_-_61348292 | 3.04 |
ENST00000539008.1
ENST00000540677.1 ENST00000542836.1 ENST00000542670.1 ENST00000535826.1 ENST00000545053.1 |
SYT7
|
synaptotagmin VII |
chr6_+_1389989 | 2.95 |
ENST00000259806.1
|
FOXF2
|
forkhead box F2 |
chr4_+_150999418 | 2.95 |
ENST00000296550.7
|
DCLK2
|
doublecortin-like kinase 2 |
chr2_+_39893043 | 2.91 |
ENST00000281961.2
|
TMEM178A
|
transmembrane protein 178A |
chr6_-_105584560 | 2.89 |
ENST00000336775.5
|
BVES
|
blood vessel epicardial substance |
chr7_+_45613958 | 2.89 |
ENST00000297323.7
|
ADCY1
|
adenylate cyclase 1 (brain) |
chr3_+_39851170 | 2.79 |
ENST00000425621.1
ENST00000396217.3 |
MYRIP
|
myosin VIIA and Rab interacting protein |
chr7_-_44365020 | 2.77 |
ENST00000395747.2
ENST00000347193.4 ENST00000346990.4 ENST00000258682.6 ENST00000353625.4 ENST00000421607.1 ENST00000424197.1 ENST00000502837.2 ENST00000350811.3 ENST00000395749.2 |
CAMK2B
|
calcium/calmodulin-dependent protein kinase II beta |
chr17_-_31404 | 2.74 |
ENST00000343572.7
|
DOC2B
|
double C2-like domains, beta |
chr1_-_85930823 | 2.72 |
ENST00000284031.8
ENST00000539042.1 |
DDAH1
|
dimethylarginine dimethylaminohydrolase 1 |
chr15_-_71146460 | 2.71 |
ENST00000344870.4
|
LARP6
|
La ribonucleoprotein domain family, member 6 |
chr14_+_104552016 | 2.68 |
ENST00000551177.1
ENST00000546892.2 ENST00000455920.2 |
ASPG
|
asparaginase homolog (S. cerevisiae) |
chrX_+_38420623 | 2.66 |
ENST00000378482.2
|
TSPAN7
|
tetraspanin 7 |
chr10_+_116853201 | 2.66 |
ENST00000527407.1
|
ATRNL1
|
attractin-like 1 |
chr2_-_224903995 | 2.65 |
ENST00000409304.1
ENST00000454956.1 ENST00000258405.4 |
SERPINE2
|
serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 2 |
chr6_+_19837592 | 2.59 |
ENST00000378700.3
|
ID4
|
inhibitor of DNA binding 4, dominant negative helix-loop-helix protein |
chr10_+_122216316 | 2.58 |
ENST00000398250.1
ENST00000439221.1 ENST00000398248.1 |
PPAPDC1A
|
phosphatidic acid phosphatase type 2 domain containing 1A |
chrX_-_128788914 | 2.56 |
ENST00000429967.1
ENST00000307484.6 |
APLN
|
apelin |
chr8_+_27491572 | 2.54 |
ENST00000301904.3
|
SCARA3
|
scavenger receptor class A, member 3 |
chr9_+_95947198 | 2.53 |
ENST00000448039.1
ENST00000297954.4 ENST00000395477.2 ENST00000395475.2 ENST00000349097.3 ENST00000427277.2 ENST00000356055.3 ENST00000432730.1 |
WNK2
|
WNK lysine deficient protein kinase 2 |
chr15_-_71146480 | 2.53 |
ENST00000299213.8
|
LARP6
|
La ribonucleoprotein domain family, member 6 |
chr7_-_32111009 | 2.52 |
ENST00000396184.3
ENST00000396189.2 ENST00000321453.7 |
PDE1C
|
phosphodiesterase 1C, calmodulin-dependent 70kDa |
chr13_+_98795434 | 2.51 |
ENST00000376586.2
|
FARP1
|
FERM, RhoGEF (ARHGEF) and pleckstrin domain protein 1 (chondrocyte-derived) |
chr14_+_67999999 | 2.50 |
ENST00000329153.5
|
PLEKHH1
|
pleckstrin homology domain containing, family H (with MyTH4 domain) member 1 |
chr6_-_94129244 | 2.50 |
ENST00000369303.4
ENST00000369297.1 |
EPHA7
|
EPH receptor A7 |
chr1_+_233749739 | 2.49 |
ENST00000366621.3
|
KCNK1
|
potassium channel, subfamily K, member 1 |
chr10_+_128593978 | 2.49 |
ENST00000280333.6
|
DOCK1
|
dedicator of cytokinesis 1 |
chr16_+_58497567 | 2.49 |
ENST00000258187.5
|
NDRG4
|
NDRG family member 4 |
chr1_+_162039558 | 2.48 |
ENST00000530878.1
ENST00000361897.5 |
NOS1AP
|
nitric oxide synthase 1 (neuronal) adaptor protein |
chr2_-_27718052 | 2.48 |
ENST00000264703.3
|
FNDC4
|
fibronectin type III domain containing 4 |
chr12_+_53440753 | 2.46 |
ENST00000379902.3
|
TENC1
|
tensin like C1 domain containing phosphatase (tensin 2) |
chr2_+_46524537 | 2.45 |
ENST00000263734.3
|
EPAS1
|
endothelial PAS domain protein 1 |
chr11_+_101981169 | 2.44 |
ENST00000526343.1
ENST00000282441.5 ENST00000537274.1 ENST00000345877.2 |
YAP1
|
Yes-associated protein 1 |
chr11_-_12030905 | 2.42 |
ENST00000326932.4
|
DKK3
|
dickkopf WNT signaling pathway inhibitor 3 |
chr20_-_39995467 | 2.38 |
ENST00000332312.3
|
EMILIN3
|
elastin microfibril interfacer 3 |
chr8_+_27491381 | 2.36 |
ENST00000337221.4
|
SCARA3
|
scavenger receptor class A, member 3 |
chr3_+_12329358 | 2.34 |
ENST00000309576.6
|
PPARG
|
peroxisome proliferator-activated receptor gamma |
chr17_+_11144580 | 2.33 |
ENST00000441885.3
ENST00000432116.3 ENST00000409168.3 |
SHISA6
|
shisa family member 6 |
chr8_+_136469684 | 2.33 |
ENST00000355849.5
|
KHDRBS3
|
KH domain containing, RNA binding, signal transduction associated 3 |
chr20_-_55841398 | 2.32 |
ENST00000395864.3
|
BMP7
|
bone morphogenetic protein 7 |
chr1_+_205473865 | 2.32 |
ENST00000506215.1
ENST00000419301.1 |
CDK18
|
cyclin-dependent kinase 18 |
chr1_-_21995794 | 2.31 |
ENST00000542643.2
ENST00000374765.4 ENST00000317967.7 |
RAP1GAP
|
RAP1 GTPase activating protein |
chr11_+_12399071 | 2.30 |
ENST00000539723.1
ENST00000550549.1 |
PARVA
|
parvin, alpha |
chr11_-_12031273 | 2.30 |
ENST00000525493.1
|
DKK3
|
dickkopf WNT signaling pathway inhibitor 3 |
chrX_+_38420783 | 2.29 |
ENST00000422612.2
ENST00000286824.6 ENST00000545599.1 |
TSPAN7
|
tetraspanin 7 |
chr3_+_50192537 | 2.25 |
ENST00000002829.3
|
SEMA3F
|
sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3F |
chr6_+_123317116 | 2.25 |
ENST00000275162.5
|
CLVS2
|
clavesin 2 |
chr20_-_55841662 | 2.24 |
ENST00000395863.3
ENST00000450594.2 |
BMP7
|
bone morphogenetic protein 7 |
chr1_+_65613852 | 2.20 |
ENST00000327299.7
|
AK4
|
adenylate kinase 4 |
chr10_+_95753714 | 2.20 |
ENST00000260766.3
|
PLCE1
|
phospholipase C, epsilon 1 |
chr1_+_205473784 | 2.19 |
ENST00000478560.1
ENST00000443813.2 |
CDK18
|
cyclin-dependent kinase 18 |
chr2_+_158733088 | 2.18 |
ENST00000605860.1
|
UPP2
|
uridine phosphorylase 2 |
chr1_-_8086343 | 2.17 |
ENST00000474874.1
ENST00000469499.1 ENST00000377482.5 |
ERRFI1
|
ERBB receptor feedback inhibitor 1 |
chr1_+_65613513 | 2.17 |
ENST00000395334.2
|
AK4
|
adenylate kinase 4 |
chr10_+_116853091 | 2.15 |
ENST00000526946.1
|
ATRNL1
|
attractin-like 1 |
chr9_+_17579084 | 2.13 |
ENST00000380607.4
|
SH3GL2
|
SH3-domain GRB2-like 2 |
chr5_-_146889619 | 2.12 |
ENST00000343218.5
|
DPYSL3
|
dihydropyrimidinase-like 3 |
chr1_+_14925173 | 2.12 |
ENST00000376030.2
ENST00000503743.1 ENST00000422387.2 |
KAZN
|
kazrin, periplakin interacting protein |
chr3_+_50192499 | 2.11 |
ENST00000413852.1
|
SEMA3F
|
sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3F |
chr7_-_32110451 | 2.10 |
ENST00000396191.1
ENST00000396182.2 |
PDE1C
|
phosphodiesterase 1C, calmodulin-dependent 70kDa |
chr15_+_80696666 | 2.09 |
ENST00000303329.4
|
ARNT2
|
aryl-hydrocarbon receptor nuclear translocator 2 |
chr5_+_38846101 | 2.09 |
ENST00000274276.3
|
OSMR
|
oncostatin M receptor |
chr1_-_21948906 | 2.08 |
ENST00000374761.2
ENST00000599760.1 |
RAP1GAP
|
RAP1 GTPase activating protein |
chr7_-_122526799 | 2.07 |
ENST00000334010.7
ENST00000313070.7 |
CADPS2
|
Ca++-dependent secretion activator 2 |
chr3_+_12329397 | 2.04 |
ENST00000397015.2
|
PPARG
|
peroxisome proliferator-activated receptor gamma |
chr16_+_86544113 | 2.04 |
ENST00000262426.4
|
FOXF1
|
forkhead box F1 |
chr3_+_50192457 | 2.04 |
ENST00000414301.1
ENST00000450338.1 |
SEMA3F
|
sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3F |
chr9_-_13279563 | 2.03 |
ENST00000541718.1
|
MPDZ
|
multiple PDZ domain protein |
chr11_-_117667806 | 2.01 |
ENST00000527706.1
ENST00000321322.6 |
DSCAML1
|
Down syndrome cell adhesion molecule like 1 |
chr9_-_91793675 | 1.99 |
ENST00000375835.4
ENST00000375830.1 |
SHC3
|
SHC (Src homology 2 domain containing) transforming protein 3 |
chr6_+_147830063 | 1.99 |
ENST00000367474.1
|
SAMD5
|
sterile alpha motif domain containing 5 |
chr15_+_57668695 | 1.98 |
ENST00000281282.5
|
CGNL1
|
cingulin-like 1 |
chr14_-_38725573 | 1.98 |
ENST00000342213.2
|
CLEC14A
|
C-type lectin domain family 14, member A |
chr2_-_241759622 | 1.98 |
ENST00000320389.7
ENST00000498729.2 |
KIF1A
|
kinesin family member 1A |
chr5_+_131593364 | 1.97 |
ENST00000253754.3
ENST00000379018.3 |
PDLIM4
|
PDZ and LIM domain 4 |
chr18_-_30050395 | 1.97 |
ENST00000269209.6
ENST00000399218.4 |
GAREM
|
GRB2 associated, regulator of MAPK1 |
chr17_-_6459802 | 1.97 |
ENST00000262483.8
|
PITPNM3
|
PITPNM family member 3 |
chr16_+_25703274 | 1.96 |
ENST00000331351.5
|
HS3ST4
|
heparan sulfate (glucosamine) 3-O-sulfotransferase 4 |
chr17_-_15165854 | 1.96 |
ENST00000395936.1
ENST00000395938.2 |
PMP22
|
peripheral myelin protein 22 |
chr8_-_22014255 | 1.95 |
ENST00000424267.2
|
LGI3
|
leucine-rich repeat LGI family, member 3 |
chr19_+_18718214 | 1.95 |
ENST00000600490.1
|
TMEM59L
|
transmembrane protein 59-like |
chr6_-_46459099 | 1.95 |
ENST00000371374.1
|
RCAN2
|
regulator of calcineurin 2 |
chr11_+_66045634 | 1.94 |
ENST00000528852.1
ENST00000311445.6 |
CNIH2
|
cornichon family AMPA receptor auxiliary protein 2 |
chr3_-_79068594 | 1.94 |
ENST00000436010.2
|
ROBO1
|
roundabout, axon guidance receptor, homolog 1 (Drosophila) |
chr1_+_205538105 | 1.93 |
ENST00000367147.4
ENST00000539267.1 |
MFSD4
|
major facilitator superfamily domain containing 4 |
chr2_+_217498105 | 1.92 |
ENST00000233809.4
|
IGFBP2
|
insulin-like growth factor binding protein 2, 36kDa |
chr19_-_11591848 | 1.92 |
ENST00000359227.3
|
ELAVL3
|
ELAV like neuron-specific RNA binding protein 3 |
chr9_-_124991124 | 1.92 |
ENST00000394319.4
ENST00000340587.3 |
LHX6
|
LIM homeobox 6 |
chr17_+_5973793 | 1.92 |
ENST00000317744.5
|
WSCD1
|
WSC domain containing 1 |
chr15_+_43886057 | 1.91 |
ENST00000441322.1
ENST00000413657.2 ENST00000453733.1 |
CKMT1B
|
creatine kinase, mitochondrial 1B |
chr11_-_47207950 | 1.91 |
ENST00000298838.6
ENST00000531226.1 ENST00000524509.1 ENST00000528201.1 ENST00000530513.1 |
PACSIN3
|
protein kinase C and casein kinase substrate in neurons 3 |
chr20_-_62462566 | 1.90 |
ENST00000245663.4
ENST00000302995.2 |
ZBTB46
|
zinc finger and BTB domain containing 46 |
chr1_+_65720089 | 1.90 |
ENST00000494710.2
|
DNAJC6
|
DnaJ (Hsp40) homolog, subfamily C, member 6 |
chr15_+_43985725 | 1.89 |
ENST00000413453.2
|
CKMT1A
|
creatine kinase, mitochondrial 1A |
chr3_+_53528659 | 1.89 |
ENST00000350061.5
|
CACNA1D
|
calcium channel, voltage-dependent, L type, alpha 1D subunit |
chr12_+_119616447 | 1.88 |
ENST00000281938.2
|
HSPB8
|
heat shock 22kDa protein 8 |
chr19_+_35521699 | 1.88 |
ENST00000415950.3
|
SCN1B
|
sodium channel, voltage-gated, type I, beta subunit |
chr13_+_44947941 | 1.88 |
ENST00000379179.3
|
SERP2
|
stress-associated endoplasmic reticulum protein family member 2 |
chr15_-_71146347 | 1.88 |
ENST00000559140.2
|
LARP6
|
La ribonucleoprotein domain family, member 6 |
chr3_-_160823158 | 1.88 |
ENST00000392779.2
ENST00000392780.1 ENST00000494173.1 |
B3GALNT1
|
beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group) |
chr9_+_137979506 | 1.87 |
ENST00000539529.1
ENST00000392991.4 ENST00000371793.3 |
OLFM1
|
olfactomedin 1 |
chr1_+_6845578 | 1.86 |
ENST00000467404.2
ENST00000439411.2 |
CAMTA1
|
calmodulin binding transcription activator 1 |
chr6_-_84419101 | 1.86 |
ENST00000520302.1
ENST00000520213.1 ENST00000439399.2 ENST00000428679.2 ENST00000437520.1 |
SNAP91
|
synaptosomal-associated protein, 91kDa |
chr5_+_135170331 | 1.86 |
ENST00000425402.1
ENST00000274513.5 ENST00000420621.1 ENST00000433282.2 ENST00000412661.2 |
SLC25A48
|
solute carrier family 25, member 48 |
chr1_+_169075554 | 1.83 |
ENST00000367815.4
|
ATP1B1
|
ATPase, Na+/K+ transporting, beta 1 polypeptide |
chr5_-_83680192 | 1.82 |
ENST00000380138.3
|
EDIL3
|
EGF-like repeats and discoidin I-like domains 3 |
chr13_-_102068706 | 1.82 |
ENST00000251127.6
|
NALCN
|
sodium leak channel, non-selective |
chr12_+_108523133 | 1.82 |
ENST00000547525.1
|
WSCD2
|
WSC domain containing 2 |
chr7_-_122526411 | 1.82 |
ENST00000449022.2
|
CADPS2
|
Ca++-dependent secretion activator 2 |
chr1_-_48462566 | 1.82 |
ENST00000606738.2
|
TRABD2B
|
TraB domain containing 2B |
chr6_-_150185156 | 1.81 |
ENST00000239367.2
ENST00000367368.2 |
LRP11
|
low density lipoprotein receptor-related protein 11 |
chr1_-_62785054 | 1.81 |
ENST00000371153.4
|
KANK4
|
KN motif and ankyrin repeat domains 4 |
chr2_+_105471969 | 1.81 |
ENST00000361360.2
|
POU3F3
|
POU class 3 homeobox 3 |
chr7_+_140774032 | 1.81 |
ENST00000565468.1
|
TMEM178B
|
transmembrane protein 178B |
chr2_-_1748214 | 1.80 |
ENST00000433670.1
ENST00000425171.1 ENST00000252804.4 |
PXDN
|
peroxidasin homolog (Drosophila) |
chr17_-_6459768 | 1.79 |
ENST00000421306.3
|
PITPNM3
|
PITPNM family member 3 |
chr5_+_15500280 | 1.78 |
ENST00000504595.1
|
FBXL7
|
F-box and leucine-rich repeat protein 7 |
chr14_-_102026643 | 1.76 |
ENST00000555882.1
ENST00000554441.1 ENST00000553729.1 ENST00000557109.1 ENST00000557532.1 ENST00000554694.1 ENST00000554735.1 ENST00000555174.1 ENST00000557661.1 |
DIO3OS
|
DIO3 opposite strand/antisense RNA (head to head) |
chr14_+_102027688 | 1.76 |
ENST00000510508.4
ENST00000359323.3 |
DIO3
|
deiodinase, iodothyronine, type III |
chr17_+_4402133 | 1.75 |
ENST00000329078.3
|
SPNS2
|
spinster homolog 2 (Drosophila) |
chr3_-_160823040 | 1.75 |
ENST00000484127.1
ENST00000492353.1 ENST00000473142.1 ENST00000468268.1 ENST00000460353.1 ENST00000320474.4 ENST00000392781.2 |
B3GALNT1
|
beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group) |
chr10_+_124221036 | 1.74 |
ENST00000368984.3
|
HTRA1
|
HtrA serine peptidase 1 |
chr17_-_78009647 | 1.74 |
ENST00000310924.2
|
TBC1D16
|
TBC1 domain family, member 16 |
chr9_-_101471479 | 1.72 |
ENST00000259455.2
|
GABBR2
|
gamma-aminobutyric acid (GABA) B receptor, 2 |
chr3_-_9595480 | 1.72 |
ENST00000287585.6
|
LHFPL4
|
lipoma HMGIC fusion partner-like 4 |
chr6_+_56820152 | 1.71 |
ENST00000370745.1
|
BEND6
|
BEN domain containing 6 |
chr15_+_68871308 | 1.71 |
ENST00000261861.5
|
CORO2B
|
coronin, actin binding protein, 2B |
chr4_-_22517620 | 1.71 |
ENST00000502482.1
ENST00000334304.5 |
GPR125
|
G protein-coupled receptor 125 |
chr16_-_65155833 | 1.71 |
ENST00000566827.1
ENST00000394156.3 ENST00000562998.1 |
CDH11
|
cadherin 11, type 2, OB-cadherin (osteoblast) |
chr1_+_15250596 | 1.71 |
ENST00000361144.5
|
KAZN
|
kazrin, periplakin interacting protein |
chrX_+_152783131 | 1.71 |
ENST00000349466.2
ENST00000370186.1 |
ATP2B3
|
ATPase, Ca++ transporting, plasma membrane 3 |
chr6_-_84418841 | 1.70 |
ENST00000369694.2
ENST00000195649.6 |
SNAP91
|
synaptosomal-associated protein, 91kDa |
chr7_-_124405681 | 1.70 |
ENST00000303921.2
|
GPR37
|
G protein-coupled receptor 37 (endothelin receptor type B-like) |
chr12_+_128751948 | 1.70 |
ENST00000435159.2
|
TMEM132C
|
transmembrane protein 132C |
chr9_-_124990680 | 1.69 |
ENST00000541397.2
ENST00000560485.1 |
LHX6
|
LIM homeobox 6 |
chr4_-_109683691 | 1.68 |
ENST00000512320.1
ENST00000510723.1 |
ETNPPL
|
ethanolamine-phosphate phospho-lyase |
chr10_+_72238517 | 1.68 |
ENST00000263563.6
|
PALD1
|
phosphatase domain containing, paladin 1 |
chr14_-_58618896 | 1.67 |
ENST00000267485.7
|
C14orf37
|
chromosome 14 open reading frame 37 |
chr21_+_38338737 | 1.66 |
ENST00000430068.1
|
AP000704.5
|
AP000704.5 |
chr16_+_58497274 | 1.66 |
ENST00000564207.1
|
NDRG4
|
NDRG family member 4 |
chr1_+_203096831 | 1.65 |
ENST00000337894.4
|
ADORA1
|
adenosine A1 receptor |
chr7_-_22396533 | 1.65 |
ENST00000344041.6
|
RAPGEF5
|
Rap guanine nucleotide exchange factor (GEF) 5 |
chr2_+_205410723 | 1.65 |
ENST00000358768.2
ENST00000351153.1 ENST00000349953.3 |
PARD3B
|
par-3 family cell polarity regulator beta |
chr22_+_51112800 | 1.65 |
ENST00000414786.2
|
SHANK3
|
SH3 and multiple ankyrin repeat domains 3 |
chr6_+_159590423 | 1.64 |
ENST00000297267.9
ENST00000340366.6 |
FNDC1
|
fibronectin type III domain containing 1 |
chr17_-_80656528 | 1.63 |
ENST00000538809.2
ENST00000269347.6 ENST00000571995.1 |
RAB40B
|
RAB40B, member RAS oncogene family |
chr19_-_38747172 | 1.63 |
ENST00000347262.4
ENST00000591585.1 ENST00000301242.4 |
PPP1R14A
|
protein phosphatase 1, regulatory (inhibitor) subunit 14A |
chr1_-_21059029 | 1.62 |
ENST00000444387.2
ENST00000375031.1 ENST00000518294.1 |
SH2D5
|
SH2 domain containing 5 |
chr2_-_86564740 | 1.62 |
ENST00000540790.1
ENST00000428491.1 |
REEP1
|
receptor accessory protein 1 |
chr5_+_38845960 | 1.62 |
ENST00000502536.1
|
OSMR
|
oncostatin M receptor |
chr21_+_44589118 | 1.62 |
ENST00000291554.2
|
CRYAA
|
crystallin, alpha A |
chr11_-_17565947 | 1.62 |
ENST00000527020.1
ENST00000318024.4 |
USH1C
|
Usher syndrome 1C (autosomal recessive, severe) |
chr15_+_41851211 | 1.61 |
ENST00000263798.3
|
TYRO3
|
TYRO3 protein tyrosine kinase |
chr3_+_50192833 | 1.61 |
ENST00000426511.1
|
SEMA3F
|
sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3F |
chr2_-_72375167 | 1.61 |
ENST00000001146.2
|
CYP26B1
|
cytochrome P450, family 26, subfamily B, polypeptide 1 |
chr2_-_86564776 | 1.61 |
ENST00000165698.5
ENST00000541910.1 ENST00000535845.1 |
REEP1
|
receptor accessory protein 1 |
chr3_+_184097905 | 1.61 |
ENST00000450923.1
|
CHRD
|
chordin |
chr7_-_82073109 | 1.60 |
ENST00000356860.3
|
CACNA2D1
|
calcium channel, voltage-dependent, alpha 2/delta subunit 1 |
chr16_-_49891694 | 1.59 |
ENST00000562520.1
|
ZNF423
|
zinc finger protein 423 |
chr12_-_96184533 | 1.59 |
ENST00000343702.4
ENST00000344911.4 |
NTN4
|
netrin 4 |
chr19_-_51143075 | 1.59 |
ENST00000600079.1
ENST00000593901.1 |
SYT3
|
synaptotagmin III |
chr19_-_49944806 | 1.58 |
ENST00000221485.3
|
SLC17A7
|
solute carrier family 17 (vesicular glutamate transporter), member 7 |
chr2_-_217560248 | 1.57 |
ENST00000233813.4
|
IGFBP5
|
insulin-like growth factor binding protein 5 |
chr2_+_205410516 | 1.57 |
ENST00000406610.2
ENST00000462231.1 |
PARD3B
|
par-3 family cell polarity regulator beta |
chr10_-_50970382 | 1.56 |
ENST00000419399.1
ENST00000432695.1 |
OGDHL
|
oxoglutarate dehydrogenase-like |
chr5_-_2751762 | 1.55 |
ENST00000302057.5
ENST00000382611.6 |
IRX2
|
iroquois homeobox 2 |
chr9_+_133971863 | 1.55 |
ENST00000372309.3
|
AIF1L
|
allograft inflammatory factor 1-like |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.7 | 6.7 | GO:1990927 | vesicle-mediated cholesterol transport(GO:0090119) short-term synaptic potentiation(GO:1990926) calcium ion regulated lysosome exocytosis(GO:1990927) |
1.5 | 4.4 | GO:1903697 | negative regulation of microvillus assembly(GO:1903697) |
1.5 | 4.4 | GO:0060931 | sinoatrial node cell development(GO:0060931) |
1.3 | 5.3 | GO:2000230 | negative regulation of pancreatic stellate cell proliferation(GO:2000230) |
1.3 | 1.3 | GO:0060738 | epithelial-mesenchymal signaling involved in prostate gland development(GO:0060738) |
1.2 | 3.7 | GO:0021919 | BMP signaling pathway involved in spinal cord dorsal/ventral patterning(GO:0021919) |
1.2 | 3.6 | GO:0060932 | Purkinje myocyte differentiation(GO:0003168) cardiac pacemaker cell fate commitment(GO:0060927) atrioventricular node cell fate commitment(GO:0060929) His-Purkinje system cell differentiation(GO:0060932) |
1.1 | 4.6 | GO:1905069 | allantois development(GO:1905069) |
1.0 | 2.9 | GO:1904530 | negative regulation of actin filament binding(GO:1904530) negative regulation of actin binding(GO:1904617) |
0.9 | 2.8 | GO:1904204 | regulation of skeletal muscle hypertrophy(GO:1904204) |
0.9 | 8.2 | GO:0060160 | negative regulation of dopamine receptor signaling pathway(GO:0060160) |
0.9 | 3.5 | GO:0032811 | negative regulation of epinephrine secretion(GO:0032811) epidermal growth factor-activated receptor transactivation by G-protein coupled receptor signaling pathway(GO:0035625) |
0.9 | 5.2 | GO:0061107 | seminal vesicle development(GO:0061107) |
0.9 | 2.6 | GO:0006579 | amino-acid betaine catabolic process(GO:0006579) |
0.9 | 2.6 | GO:0051466 | positive regulation of corticotropin-releasing hormone secretion(GO:0051466) |
0.8 | 2.5 | GO:0035604 | fibroblast growth factor receptor signaling pathway involved in negative regulation of apoptotic process in bone marrow(GO:0035602) fibroblast growth factor receptor signaling pathway involved in hemopoiesis(GO:0035603) fibroblast growth factor receptor signaling pathway involved in positive regulation of cell proliferation in bone marrow(GO:0035604) |
0.8 | 2.5 | GO:1905033 | positive regulation of voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization(GO:1903762) positive regulation of ventricular cardiac muscle cell action potential(GO:1903947) positive regulation of membrane repolarization during ventricular cardiac muscle cell action potential(GO:1905026) positive regulation of membrane repolarization during cardiac muscle cell action potential(GO:1905033) |
0.8 | 3.3 | GO:0061304 | retinal blood vessel morphogenesis(GO:0061304) |
0.8 | 3.2 | GO:1903984 | positive regulation of TRAIL-activated apoptotic signaling pathway(GO:1903984) |
0.8 | 3.1 | GO:1904049 | negative regulation of spontaneous neurotransmitter secretion(GO:1904049) |
0.7 | 5.8 | GO:0032345 | negative regulation of aldosterone metabolic process(GO:0032345) negative regulation of aldosterone biosynthetic process(GO:0032348) negative regulation of cortisol biosynthetic process(GO:2000065) |
0.7 | 3.6 | GO:2000672 | negative regulation of motor neuron apoptotic process(GO:2000672) |
0.7 | 7.1 | GO:0070100 | negative regulation of chemokine-mediated signaling pathway(GO:0070100) |
0.7 | 2.1 | GO:0021966 | corticospinal neuron axon guidance(GO:0021966) |
0.7 | 2.8 | GO:0035426 | extracellular matrix-cell signaling(GO:0035426) |
0.7 | 5.6 | GO:0003065 | positive regulation of heart rate by epinephrine(GO:0003065) |
0.7 | 6.9 | GO:1990504 | dense core granule exocytosis(GO:1990504) |
0.7 | 6.9 | GO:0046940 | nucleoside monophosphate phosphorylation(GO:0046940) |
0.7 | 2.0 | GO:0007439 | ectodermal digestive tract development(GO:0007439) embryonic ectodermal digestive tract development(GO:0048611) right lung development(GO:0060458) |
0.7 | 9.2 | GO:0036484 | trunk segmentation(GO:0035290) trunk neural crest cell migration(GO:0036484) ventral trunk neural crest cell migration(GO:0036486) |
0.6 | 2.6 | GO:1904106 | protein localization to microvillus(GO:1904106) |
0.6 | 3.1 | GO:0097089 | methyl-branched fatty acid metabolic process(GO:0097089) |
0.6 | 4.8 | GO:0021800 | cerebral cortex tangential migration(GO:0021800) |
0.6 | 4.7 | GO:0051549 | positive regulation of keratinocyte migration(GO:0051549) |
0.6 | 1.7 | GO:0097187 | dentinogenesis(GO:0097187) |
0.6 | 2.9 | GO:0042412 | taurine biosynthetic process(GO:0042412) |
0.6 | 1.1 | GO:1904978 | regulation of endosome organization(GO:1904978) |
0.6 | 1.7 | GO:0060730 | regulation of intestinal epithelial structure maintenance(GO:0060730) |
0.6 | 7.2 | GO:0060449 | bud elongation involved in lung branching(GO:0060449) |
0.6 | 1.7 | GO:0032242 | regulation of nucleoside transport(GO:0032242) |
0.5 | 1.6 | GO:0048170 | positive regulation of long-term neuronal synaptic plasticity(GO:0048170) |
0.5 | 1.6 | GO:0042137 | sequestering of neurotransmitter(GO:0042137) |
0.5 | 5.4 | GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
0.5 | 1.6 | GO:1902811 | tongue muscle cell differentiation(GO:0035981) positive regulation of skeletal muscle fiber differentiation(GO:1902811) regulation of tongue muscle cell differentiation(GO:2001035) positive regulation of tongue muscle cell differentiation(GO:2001037) |
0.5 | 1.5 | GO:0034059 | response to anoxia(GO:0034059) |
0.5 | 0.5 | GO:0097102 | endothelial tip cell fate specification(GO:0097102) |
0.5 | 1.9 | GO:1902683 | regulation of receptor localization to synapse(GO:1902683) |
0.5 | 6.5 | GO:2000601 | positive regulation of Arp2/3 complex-mediated actin nucleation(GO:2000601) |
0.5 | 0.9 | GO:0061034 | olfactory bulb mitral cell layer development(GO:0061034) |
0.5 | 3.7 | GO:0038165 | oncostatin-M-mediated signaling pathway(GO:0038165) |
0.5 | 5.4 | GO:0060075 | regulation of resting membrane potential(GO:0060075) |
0.5 | 1.8 | GO:1904808 | regulation of protein oxidation(GO:1904806) positive regulation of protein oxidation(GO:1904808) |
0.4 | 2.2 | GO:0007509 | mesoderm migration involved in gastrulation(GO:0007509) |
0.4 | 2.2 | GO:0046108 | uridine metabolic process(GO:0046108) |
0.4 | 2.6 | GO:0072069 | DCT cell differentiation(GO:0072069) metanephric DCT cell differentiation(GO:0072240) |
0.4 | 6.8 | GO:0030050 | vesicle transport along actin filament(GO:0030050) |
0.4 | 3.4 | GO:0086048 | membrane depolarization during bundle of His cell action potential(GO:0086048) |
0.4 | 1.6 | GO:0072086 | specification of loop of Henle identity(GO:0072086) |
0.4 | 2.3 | GO:0006651 | diacylglycerol biosynthetic process(GO:0006651) |
0.4 | 1.1 | GO:0070407 | oxidation-dependent protein catabolic process(GO:0070407) |
0.4 | 1.9 | GO:0034334 | adherens junction maintenance(GO:0034334) |
0.4 | 2.2 | GO:0098886 | modification of dendritic spine(GO:0098886) |
0.4 | 1.1 | GO:0034164 | negative regulation of toll-like receptor 9 signaling pathway(GO:0034164) |
0.4 | 1.1 | GO:0034226 | lysine import(GO:0034226) L-lysine import(GO:0061461) L-lysine import into cell(GO:1903410) |
0.4 | 1.8 | GO:0048073 | regulation of eye pigmentation(GO:0048073) |
0.3 | 4.2 | GO:0051823 | regulation of synapse structural plasticity(GO:0051823) |
0.3 | 1.0 | GO:0003220 | left ventricular cardiac muscle tissue morphogenesis(GO:0003220) |
0.3 | 1.4 | GO:0006535 | cysteine biosynthetic process from serine(GO:0006535) |
0.3 | 1.4 | GO:0072138 | mesenchymal cell proliferation involved in ureteric bud development(GO:0072138) |
0.3 | 1.0 | GO:1903966 | monounsaturated fatty acid metabolic process(GO:1903964) monounsaturated fatty acid biosynthetic process(GO:1903966) |
0.3 | 0.6 | GO:0010701 | positive regulation of norepinephrine secretion(GO:0010701) |
0.3 | 1.8 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
0.3 | 1.8 | GO:0014807 | regulation of somitogenesis(GO:0014807) |
0.3 | 0.9 | GO:0060054 | positive regulation of epithelial cell proliferation involved in wound healing(GO:0060054) |
0.3 | 0.9 | GO:1904956 | regulation of midbrain dopaminergic neuron differentiation(GO:1904956) |
0.3 | 3.2 | GO:0016191 | synaptic vesicle uncoating(GO:0016191) |
0.3 | 0.9 | GO:0006424 | glutamyl-tRNA aminoacylation(GO:0006424) |
0.3 | 2.3 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
0.3 | 2.0 | GO:0003199 | endocardial cushion to mesenchymal transition involved in heart valve formation(GO:0003199) |
0.3 | 2.8 | GO:0045218 | zonula adherens maintenance(GO:0045218) |
0.3 | 1.4 | GO:0019464 | glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
0.3 | 1.1 | GO:0034444 | regulation of plasma lipoprotein particle oxidation(GO:0034444) negative regulation of plasma lipoprotein particle oxidation(GO:0034445) phenylpropanoid catabolic process(GO:0046271) |
0.3 | 0.8 | GO:0043000 | Golgi to plasma membrane CFTR protein transport(GO:0043000) |
0.3 | 3.6 | GO:0055059 | asymmetric neuroblast division(GO:0055059) |
0.3 | 1.9 | GO:0060179 | male mating behavior(GO:0060179) |
0.3 | 0.8 | GO:0072720 | cellular response to mycotoxin(GO:0036146) response to dithiothreitol(GO:0072720) |
0.3 | 1.1 | GO:0060166 | olfactory pit development(GO:0060166) |
0.3 | 0.8 | GO:0035623 | renal glucose absorption(GO:0035623) |
0.3 | 1.8 | GO:0044861 | protein transport into plasma membrane raft(GO:0044861) positive regulation of calcium:sodium antiporter activity(GO:1903281) |
0.3 | 1.0 | GO:0014054 | positive regulation of gamma-aminobutyric acid secretion(GO:0014054) |
0.3 | 0.8 | GO:0060490 | orthogonal dichotomous subdivision of terminal units involved in lung branching morphogenesis(GO:0060488) planar dichotomous subdivision of terminal units involved in lung branching morphogenesis(GO:0060489) lateral sprouting involved in lung morphogenesis(GO:0060490) |
0.2 | 1.0 | GO:1900535 | medium-chain fatty-acyl-CoA catabolic process(GO:0036114) long-chain fatty-acyl-CoA catabolic process(GO:0036116) palmitic acid metabolic process(GO:1900533) palmitic acid biosynthetic process(GO:1900535) |
0.2 | 1.0 | GO:0031133 | regulation of axon diameter(GO:0031133) |
0.2 | 3.2 | GO:0009414 | response to water deprivation(GO:0009414) |
0.2 | 1.2 | GO:0003278 | apoptotic process involved in heart morphogenesis(GO:0003278) |
0.2 | 0.7 | GO:0046855 | polyol catabolic process(GO:0046174) phosphorylated carbohydrate dephosphorylation(GO:0046838) inositol phosphate dephosphorylation(GO:0046855) inositol phosphate catabolic process(GO:0071545) |
0.2 | 2.7 | GO:0006528 | asparagine metabolic process(GO:0006528) |
0.2 | 2.5 | GO:0043129 | surfactant homeostasis(GO:0043129) |
0.2 | 0.7 | GO:0021644 | vagus nerve morphogenesis(GO:0021644) chemorepulsion of branchiomotor axon(GO:0021793) |
0.2 | 1.2 | GO:1904158 | axonemal central apparatus assembly(GO:1904158) |
0.2 | 0.7 | GO:2000393 | negative regulation of lamellipodium morphogenesis(GO:2000393) |
0.2 | 1.2 | GO:1902228 | mammary gland fat development(GO:0060611) positive regulation of macrophage colony-stimulating factor signaling pathway(GO:1902228) positive regulation of response to macrophage colony-stimulating factor(GO:1903971) positive regulation of cellular response to macrophage colony-stimulating factor stimulus(GO:1903974) positive regulation of microglial cell migration(GO:1904141) |
0.2 | 1.4 | GO:0099540 | synaptic signaling via neuropeptide(GO:0099538) trans-synaptic signaling by neuropeptide(GO:0099540) trans-synaptic signaling by neuropeptide, modulating synaptic transmission(GO:0099551) |
0.2 | 1.9 | GO:0086046 | membrane depolarization during SA node cell action potential(GO:0086046) |
0.2 | 4.9 | GO:2001135 | regulation of endocytic recycling(GO:2001135) |
0.2 | 2.3 | GO:0038007 | netrin-activated signaling pathway(GO:0038007) |
0.2 | 2.5 | GO:0048671 | negative regulation of collateral sprouting(GO:0048671) |
0.2 | 2.7 | GO:0046549 | retinal cone cell differentiation(GO:0042670) retinal cone cell development(GO:0046549) |
0.2 | 2.9 | GO:0021860 | pyramidal neuron development(GO:0021860) |
0.2 | 0.4 | GO:0032289 | central nervous system myelin formation(GO:0032289) |
0.2 | 3.7 | GO:1904321 | response to forskolin(GO:1904321) cellular response to forskolin(GO:1904322) |
0.2 | 1.1 | GO:1901382 | chorionic trophoblast cell proliferation(GO:0097360) regulation of chorionic trophoblast cell proliferation(GO:1901382) |
0.2 | 2.6 | GO:0032966 | negative regulation of collagen biosynthetic process(GO:0032966) |
0.2 | 0.2 | GO:0060594 | mammary gland specification(GO:0060594) |
0.2 | 1.5 | GO:0050915 | sensory perception of sour taste(GO:0050915) |
0.2 | 2.6 | GO:1900028 | negative regulation of ruffle assembly(GO:1900028) |
0.2 | 1.7 | GO:0015822 | ornithine transport(GO:0015822) |
0.2 | 1.7 | GO:0031987 | locomotion involved in locomotory behavior(GO:0031987) |
0.2 | 0.6 | GO:0072205 | metanephric collecting duct development(GO:0072205) |
0.2 | 1.9 | GO:0045650 | negative regulation of macrophage differentiation(GO:0045650) |
0.2 | 1.9 | GO:0072282 | metanephric nephron tubule morphogenesis(GO:0072282) |
0.2 | 0.8 | GO:0001994 | norepinephrine-epinephrine vasoconstriction involved in regulation of systemic arterial blood pressure(GO:0001994) |
0.2 | 0.2 | GO:0072034 | renal vesicle induction(GO:0072034) |
0.2 | 4.6 | GO:0009650 | UV protection(GO:0009650) |
0.2 | 1.2 | GO:0035900 | response to isolation stress(GO:0035900) |
0.2 | 1.8 | GO:0098532 | histone H3-K27 trimethylation(GO:0098532) |
0.2 | 1.2 | GO:0003383 | apical constriction(GO:0003383) |
0.2 | 2.3 | GO:0071670 | smooth muscle cell chemotaxis(GO:0071670) |
0.2 | 1.9 | GO:0045636 | positive regulation of melanocyte differentiation(GO:0045636) |
0.2 | 0.6 | GO:1902303 | regulation of heart rate by hormone(GO:0003064) negative regulation of potassium ion export(GO:1902303) |
0.2 | 1.5 | GO:0021869 | forebrain ventricular zone progenitor cell division(GO:0021869) |
0.2 | 0.9 | GO:0038098 | sequestering of BMP from receptor via BMP binding(GO:0038098) |
0.2 | 0.9 | GO:1901994 | negative regulation of meiotic cell cycle phase transition(GO:1901994) |
0.2 | 1.7 | GO:0003190 | atrioventricular valve formation(GO:0003190) |
0.2 | 1.3 | GO:0002028 | regulation of sodium ion transport(GO:0002028) |
0.2 | 0.7 | GO:0014050 | negative regulation of glutamate secretion(GO:0014050) |
0.2 | 1.6 | GO:0098814 | spontaneous neurotransmitter secretion(GO:0061669) spontaneous synaptic transmission(GO:0098814) |
0.2 | 0.9 | GO:0046726 | positive regulation by virus of viral protein levels in host cell(GO:0046726) |
0.2 | 0.2 | GO:0048371 | lateral mesodermal cell differentiation(GO:0048371) |
0.2 | 5.2 | GO:0009312 | oligosaccharide biosynthetic process(GO:0009312) |
0.2 | 0.5 | GO:0032290 | peripheral nervous system myelin formation(GO:0032290) |
0.2 | 3.9 | GO:0048172 | regulation of short-term neuronal synaptic plasticity(GO:0048172) |
0.2 | 1.1 | GO:0060214 | endocardium formation(GO:0060214) |
0.2 | 6.6 | GO:2000369 | regulation of clathrin-mediated endocytosis(GO:2000369) |
0.2 | 0.5 | GO:0070563 | negative regulation of vitamin D receptor signaling pathway(GO:0070563) |
0.2 | 3.7 | GO:0071786 | endoplasmic reticulum tubular network organization(GO:0071786) |
0.2 | 2.0 | GO:0061000 | negative regulation of dendritic spine development(GO:0061000) |
0.2 | 1.2 | GO:0015798 | myo-inositol transport(GO:0015798) |
0.2 | 1.0 | GO:0070086 | ubiquitin-dependent endocytosis(GO:0070086) |
0.2 | 0.8 | GO:0043553 | vascular endothelial growth factor receptor-2 signaling pathway(GO:0036324) negative regulation of phosphatidylinositol 3-kinase activity(GO:0043553) |
0.2 | 7.7 | GO:0045746 | negative regulation of Notch signaling pathway(GO:0045746) |
0.2 | 1.0 | GO:0021894 | cerebral cortex GABAergic interneuron differentiation(GO:0021892) cerebral cortex GABAergic interneuron development(GO:0021894) |
0.2 | 0.8 | GO:1900039 | positive regulation of cellular response to hypoxia(GO:1900039) |
0.2 | 4.8 | GO:0042135 | neurotransmitter catabolic process(GO:0042135) |
0.2 | 2.9 | GO:0097369 | sodium ion import(GO:0097369) |
0.2 | 0.5 | GO:0046010 | positive regulation of circadian sleep/wake cycle, non-REM sleep(GO:0046010) |
0.2 | 0.6 | GO:0048631 | regulation of skeletal muscle tissue growth(GO:0048631) |
0.2 | 4.5 | GO:0032060 | bleb assembly(GO:0032060) |
0.2 | 4.9 | GO:0006646 | phosphatidylethanolamine biosynthetic process(GO:0006646) |
0.2 | 0.5 | GO:0015920 | lipopolysaccharide transport(GO:0015920) |
0.2 | 1.2 | GO:0046952 | ketone body catabolic process(GO:0046952) |
0.2 | 0.9 | GO:0060979 | vasculogenesis involved in coronary vascular morphogenesis(GO:0060979) |
0.1 | 2.2 | GO:0090336 | positive regulation of brown fat cell differentiation(GO:0090336) |
0.1 | 0.6 | GO:2000097 | regulation of smooth muscle cell-matrix adhesion(GO:2000097) |
0.1 | 4.0 | GO:0030208 | dermatan sulfate biosynthetic process(GO:0030208) |
0.1 | 0.7 | GO:0032474 | otolith morphogenesis(GO:0032474) |
0.1 | 0.3 | GO:0015819 | lysine transport(GO:0015819) L-lysine transport(GO:1902022) L-lysine transmembrane transport(GO:1903401) |
0.1 | 1.5 | GO:0006930 | substrate-dependent cell migration, cell extension(GO:0006930) |
0.1 | 3.6 | GO:0035988 | chondrocyte proliferation(GO:0035988) |
0.1 | 0.7 | GO:1903615 | regulation of protein tyrosine phosphatase activity(GO:1903613) positive regulation of protein tyrosine phosphatase activity(GO:1903615) |
0.1 | 0.5 | GO:0006663 | platelet activating factor biosynthetic process(GO:0006663) |
0.1 | 0.3 | GO:0071810 | regulation of fever generation by regulation of prostaglandin secretion(GO:0071810) positive regulation of fever generation by positive regulation of prostaglandin secretion(GO:0071812) positive regulation of ERK1 and ERK2 cascade via TNFSF11-mediated signaling(GO:0071848) regulation of fever generation by prostaglandin secretion(GO:0100009) |
0.1 | 2.6 | GO:1900038 | negative regulation of cellular response to hypoxia(GO:1900038) |
0.1 | 2.3 | GO:0071578 | zinc II ion transmembrane import(GO:0071578) |
0.1 | 4.0 | GO:0039702 | viral budding via host ESCRT complex(GO:0039702) |
0.1 | 3.4 | GO:0051639 | actin filament network formation(GO:0051639) |
0.1 | 0.4 | GO:0048549 | positive regulation of pinocytosis(GO:0048549) |
0.1 | 0.6 | GO:0044856 | plasma membrane raft distribution(GO:0044855) plasma membrane raft localization(GO:0044856) plasma membrane raft polarization(GO:0044858) regulation of plasma membrane raft polarization(GO:1903906) |
0.1 | 2.1 | GO:0008090 | retrograde axonal transport(GO:0008090) |
0.1 | 0.9 | GO:2000124 | regulation of endocannabinoid signaling pathway(GO:2000124) |
0.1 | 0.6 | GO:0014886 | transition between slow and fast fiber(GO:0014886) |
0.1 | 2.9 | GO:0042249 | establishment of planar polarity of embryonic epithelium(GO:0042249) |
0.1 | 0.8 | GO:1900122 | positive regulation of receptor binding(GO:1900122) |
0.1 | 0.4 | GO:0046168 | glycerol-3-phosphate catabolic process(GO:0046168) |
0.1 | 0.8 | GO:0008218 | bioluminescence(GO:0008218) |
0.1 | 1.3 | GO:0016560 | protein import into peroxisome matrix, docking(GO:0016560) |
0.1 | 0.8 | GO:0032377 | regulation of intracellular lipid transport(GO:0032377) regulation of intracellular sterol transport(GO:0032380) regulation of intracellular cholesterol transport(GO:0032383) |
0.1 | 0.5 | GO:0001971 | negative regulation of activation of membrane attack complex(GO:0001971) |
0.1 | 0.5 | GO:0006987 | activation of signaling protein activity involved in unfolded protein response(GO:0006987) |
0.1 | 1.0 | GO:0035494 | SNARE complex disassembly(GO:0035494) |
0.1 | 1.3 | GO:0046959 | habituation(GO:0046959) |
0.1 | 0.7 | GO:1900748 | positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
0.1 | 1.7 | GO:0021957 | corticospinal tract morphogenesis(GO:0021957) |
0.1 | 0.7 | GO:0055014 | atrial cardiac muscle cell differentiation(GO:0055011) atrial cardiac muscle cell development(GO:0055014) |
0.1 | 2.6 | GO:0038063 | collagen-activated tyrosine kinase receptor signaling pathway(GO:0038063) |
0.1 | 0.1 | GO:2000583 | regulation of platelet-derived growth factor receptor-alpha signaling pathway(GO:2000583) negative regulation of platelet-derived growth factor receptor-alpha signaling pathway(GO:2000584) |
0.1 | 0.7 | GO:0060385 | axonogenesis involved in innervation(GO:0060385) |
0.1 | 0.4 | GO:0097498 | endothelial tube lumen extension(GO:0097498) |
0.1 | 0.3 | GO:0048210 | Golgi vesicle fusion to target membrane(GO:0048210) |
0.1 | 0.4 | GO:0071469 | sensory perception of touch(GO:0050975) detection of mechanical stimulus involved in sensory perception of touch(GO:0050976) cellular response to alkaline pH(GO:0071469) |
0.1 | 1.9 | GO:0051044 | positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
0.1 | 1.1 | GO:0018344 | protein geranylgeranylation(GO:0018344) |
0.1 | 0.4 | GO:0046900 | tetrahydrofolylpolyglutamate metabolic process(GO:0046900) |
0.1 | 0.1 | GO:0003331 | regulation of extracellular matrix constituent secretion(GO:0003330) positive regulation of extracellular matrix constituent secretion(GO:0003331) |
0.1 | 0.6 | GO:0019626 | short-chain fatty acid catabolic process(GO:0019626) |
0.1 | 0.4 | GO:0018277 | protein deamination(GO:0018277) |
0.1 | 1.2 | GO:2000576 | positive regulation of microtubule motor activity(GO:2000576) regulation of ATP-dependent microtubule motor activity, plus-end-directed(GO:2000580) positive regulation of ATP-dependent microtubule motor activity, plus-end-directed(GO:2000582) |
0.1 | 1.5 | GO:0034638 | phosphatidylcholine catabolic process(GO:0034638) |
0.1 | 1.0 | GO:0016198 | axon choice point recognition(GO:0016198) |
0.1 | 0.8 | GO:0060355 | positive regulation of cell adhesion molecule production(GO:0060355) |
0.1 | 1.2 | GO:0007168 | receptor guanylyl cyclase signaling pathway(GO:0007168) |
0.1 | 1.6 | GO:0002934 | desmosome organization(GO:0002934) |
0.1 | 0.3 | GO:0015743 | thiosulfate transport(GO:0015709) oxaloacetate transport(GO:0015729) malate transport(GO:0015743) malate transmembrane transport(GO:0071423) oxaloacetate(2-) transmembrane transport(GO:1902356) |
0.1 | 0.6 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
0.1 | 0.6 | GO:0007157 | heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0007157) |
0.1 | 1.6 | GO:0060068 | vagina development(GO:0060068) |
0.1 | 0.7 | GO:0002329 | pre-B cell differentiation(GO:0002329) |
0.1 | 0.5 | GO:0048636 | positive regulation of striated muscle tissue development(GO:0045844) positive regulation of muscle organ development(GO:0048636) positive regulation of muscle tissue development(GO:1901863) |
0.1 | 0.8 | GO:0097105 | presynaptic membrane assembly(GO:0097105) |
0.1 | 7.0 | GO:0045773 | positive regulation of axon extension(GO:0045773) |
0.1 | 1.8 | GO:0046069 | cGMP catabolic process(GO:0046069) |
0.1 | 2.1 | GO:0051764 | actin crosslink formation(GO:0051764) |
0.1 | 2.1 | GO:0007220 | Notch receptor processing(GO:0007220) |
0.1 | 1.5 | GO:0032780 | negative regulation of ATPase activity(GO:0032780) |
0.1 | 0.5 | GO:0071313 | cellular response to caffeine(GO:0071313) |
0.1 | 0.5 | GO:0052565 | response to defense-related nitric oxide production by other organism involved in symbiotic interaction(GO:0052551) response to defense-related host nitric oxide production(GO:0052565) |
0.1 | 0.9 | GO:1904179 | positive regulation of adipose tissue development(GO:1904179) |
0.1 | 1.5 | GO:0007614 | short-term memory(GO:0007614) |
0.1 | 1.3 | GO:0008595 | tripartite regional subdivision(GO:0007351) anterior/posterior axis specification, embryo(GO:0008595) |
0.1 | 2.7 | GO:0045956 | positive regulation of calcium ion-dependent exocytosis(GO:0045956) |
0.1 | 0.6 | GO:0021891 | olfactory bulb interneuron development(GO:0021891) |
0.1 | 0.4 | GO:0060282 | positive regulation of oocyte development(GO:0060282) |
0.1 | 0.3 | GO:0006667 | sphinganine metabolic process(GO:0006667) |
0.1 | 0.9 | GO:0046146 | tetrahydrobiopterin biosynthetic process(GO:0006729) tetrahydrobiopterin metabolic process(GO:0046146) |
0.1 | 1.7 | GO:0005513 | detection of calcium ion(GO:0005513) |
0.1 | 0.5 | GO:0060087 | relaxation of vascular smooth muscle(GO:0060087) |
0.1 | 0.4 | GO:0048104 | establishment of body hair or bristle planar orientation(GO:0048104) establishment of body hair planar orientation(GO:0048105) |
0.1 | 0.7 | GO:0097084 | vascular smooth muscle cell development(GO:0097084) |
0.1 | 1.1 | GO:0035845 | photoreceptor cell outer segment organization(GO:0035845) |
0.1 | 0.8 | GO:0010265 | SCF complex assembly(GO:0010265) |
0.1 | 2.5 | GO:2000651 | positive regulation of sodium ion transmembrane transporter activity(GO:2000651) |
0.1 | 1.1 | GO:0015693 | magnesium ion transport(GO:0015693) |
0.1 | 1.0 | GO:0003084 | positive regulation of systemic arterial blood pressure(GO:0003084) |
0.1 | 9.6 | GO:0010923 | negative regulation of phosphatase activity(GO:0010923) |
0.1 | 0.2 | GO:0021986 | epithalamus development(GO:0021538) habenula development(GO:0021986) |
0.1 | 1.5 | GO:0016576 | histone dephosphorylation(GO:0016576) |
0.1 | 0.5 | GO:0070164 | negative regulation of adiponectin secretion(GO:0070164) |
0.1 | 1.5 | GO:1904261 | regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904259) positive regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904261) basement membrane assembly involved in embryonic body morphogenesis(GO:2001197) |
0.1 | 0.3 | GO:0034499 | late endosome to Golgi transport(GO:0034499) |
0.1 | 2.5 | GO:0043567 | regulation of insulin-like growth factor receptor signaling pathway(GO:0043567) |
0.1 | 0.5 | GO:0051012 | microtubule sliding(GO:0051012) |
0.1 | 0.3 | GO:1903660 | negative regulation of complement-dependent cytotoxicity(GO:1903660) |
0.1 | 0.6 | GO:0006537 | glutamate biosynthetic process(GO:0006537) |
0.1 | 0.4 | GO:0008588 | release of cytoplasmic sequestered NF-kappaB(GO:0008588) |
0.1 | 2.5 | GO:0008089 | anterograde axonal transport(GO:0008089) |
0.1 | 0.2 | GO:0006106 | fumarate metabolic process(GO:0006106) aspartate biosynthetic process(GO:0006532) aspartate catabolic process(GO:0006533) |
0.1 | 0.6 | GO:1990009 | retinal cell apoptotic process(GO:1990009) |
0.1 | 0.3 | GO:1904715 | negative regulation of chaperone-mediated autophagy(GO:1904715) |
0.1 | 0.7 | GO:0071394 | cellular response to testosterone stimulus(GO:0071394) |
0.1 | 3.7 | GO:0045671 | negative regulation of osteoclast differentiation(GO:0045671) |
0.1 | 0.7 | GO:0043615 | astrocyte cell migration(GO:0043615) |
0.1 | 0.1 | GO:1905098 | negative regulation of guanyl-nucleotide exchange factor activity(GO:1905098) |
0.1 | 1.2 | GO:0009086 | methionine biosynthetic process(GO:0009086) |
0.1 | 1.0 | GO:0002862 | negative regulation of inflammatory response to antigenic stimulus(GO:0002862) |
0.1 | 0.2 | GO:0031860 | telomeric 3' overhang formation(GO:0031860) |
0.1 | 0.5 | GO:1903244 | positive regulation of cardiac muscle adaptation(GO:0010615) positive regulation of cardiac muscle hypertrophy in response to stress(GO:1903244) |
0.1 | 0.3 | GO:0010430 | fatty acid omega-oxidation(GO:0010430) |
0.1 | 0.9 | GO:0070327 | thyroid hormone transport(GO:0070327) |
0.1 | 2.1 | GO:0042744 | hydrogen peroxide catabolic process(GO:0042744) |
0.1 | 4.5 | GO:0050885 | neuromuscular process controlling balance(GO:0050885) |
0.1 | 1.6 | GO:0006975 | DNA damage induced protein phosphorylation(GO:0006975) |
0.1 | 0.6 | GO:0000395 | mRNA 5'-splice site recognition(GO:0000395) |
0.1 | 0.2 | GO:0072298 | posterior midgut development(GO:0007497) regulation of metanephric glomerulus development(GO:0072298) positive regulation of metanephric glomerulus development(GO:0072300) |
0.1 | 0.1 | GO:0038031 | non-canonical Wnt signaling pathway via JNK cascade(GO:0038031) |
0.1 | 0.3 | GO:0044210 | 'de novo' CTP biosynthetic process(GO:0044210) |
0.1 | 0.5 | GO:0007016 | cytoskeletal anchoring at plasma membrane(GO:0007016) |
0.1 | 0.8 | GO:2000311 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000311) |
0.1 | 2.3 | GO:0043090 | amino acid import(GO:0043090) |
0.1 | 1.6 | GO:0035268 | protein mannosylation(GO:0035268) |
0.1 | 1.1 | GO:0033197 | response to vitamin E(GO:0033197) |
0.1 | 1.0 | GO:0060155 | platelet dense granule organization(GO:0060155) |
0.1 | 0.4 | GO:0033489 | cholesterol biosynthetic process via desmosterol(GO:0033489) cholesterol biosynthetic process via lathosterol(GO:0033490) |
0.1 | 0.6 | GO:0010040 | response to iron(II) ion(GO:0010040) |
0.1 | 0.4 | GO:2000346 | negative regulation of hepatocyte proliferation(GO:2000346) |
0.1 | 0.2 | GO:1903515 | regulation of calcium ion-dependent exocytosis of neurotransmitter(GO:1903233) calcium ion transport from cytosol to endoplasmic reticulum(GO:1903515) |
0.1 | 0.7 | GO:0061051 | positive regulation of cell growth involved in cardiac muscle cell development(GO:0061051) |
0.1 | 0.7 | GO:0048148 | behavioral response to cocaine(GO:0048148) |
0.1 | 0.8 | GO:0044341 | sodium-dependent phosphate transport(GO:0044341) |
0.1 | 0.5 | GO:0008343 | adult feeding behavior(GO:0008343) |
0.1 | 1.3 | GO:0097120 | receptor localization to synapse(GO:0097120) |
0.1 | 1.8 | GO:0045332 | phospholipid translocation(GO:0045332) |
0.1 | 0.5 | GO:0032074 | negative regulation of nuclease activity(GO:0032074) |
0.1 | 0.5 | GO:0098722 | asymmetric stem cell division(GO:0098722) |
0.1 | 0.5 | GO:0006659 | phosphatidylserine biosynthetic process(GO:0006659) |
0.1 | 0.6 | GO:0046826 | negative regulation of protein export from nucleus(GO:0046826) |
0.1 | 0.4 | GO:1902866 | regulation of retina development in camera-type eye(GO:1902866) |
0.1 | 0.2 | GO:0017186 | peptidyl-pyroglutamic acid biosynthetic process, using glutaminyl-peptide cyclotransferase(GO:0017186) |
0.1 | 2.0 | GO:1903861 | positive regulation of dendrite extension(GO:1903861) |
0.1 | 0.2 | GO:2001226 | negative regulation of chloride transport(GO:2001226) |
0.1 | 0.6 | GO:0051694 | pointed-end actin filament capping(GO:0051694) |
0.1 | 1.5 | GO:0043651 | linoleic acid metabolic process(GO:0043651) |
0.1 | 0.4 | GO:0034465 | response to carbon monoxide(GO:0034465) |
0.1 | 1.0 | GO:0031643 | positive regulation of myelination(GO:0031643) |
0.1 | 0.2 | GO:0001869 | regulation of complement activation, lectin pathway(GO:0001868) negative regulation of complement activation, lectin pathway(GO:0001869) |
0.1 | 0.3 | GO:0070829 | response to vitamin B2(GO:0033274) heterochromatin maintenance(GO:0070829) |
0.1 | 0.5 | GO:0001886 | endothelial cell morphogenesis(GO:0001886) |
0.0 | 0.3 | GO:0030309 | poly-N-acetyllactosamine metabolic process(GO:0030309) |
0.0 | 0.5 | GO:2001224 | positive regulation of neuron migration(GO:2001224) |
0.0 | 1.0 | GO:0010745 | negative regulation of macrophage derived foam cell differentiation(GO:0010745) |
0.0 | 2.3 | GO:0018146 | keratan sulfate biosynthetic process(GO:0018146) |
0.0 | 3.3 | GO:0035987 | endodermal cell differentiation(GO:0035987) |
0.0 | 1.3 | GO:0048488 | synaptic vesicle endocytosis(GO:0048488) |
0.0 | 0.3 | GO:0043280 | positive regulation of cysteine-type endopeptidase activity involved in apoptotic process(GO:0043280) |
0.0 | 2.0 | GO:0006099 | tricarboxylic acid cycle(GO:0006099) |
0.0 | 0.5 | GO:0097033 | respiratory chain complex III assembly(GO:0017062) mitochondrial respiratory chain complex III assembly(GO:0034551) mitochondrial respiratory chain complex III biogenesis(GO:0097033) |
0.0 | 1.1 | GO:0019511 | peptidyl-proline hydroxylation(GO:0019511) |
0.0 | 0.2 | GO:0006566 | threonine metabolic process(GO:0006566) |
0.0 | 0.2 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
0.0 | 1.0 | GO:0070262 | peptidyl-serine dephosphorylation(GO:0070262) |
0.0 | 0.5 | GO:0007256 | activation of JNKK activity(GO:0007256) |
0.0 | 0.7 | GO:0070431 | nucleotide-binding oligomerization domain containing 2 signaling pathway(GO:0070431) |
0.0 | 0.9 | GO:0033539 | fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
0.0 | 0.8 | GO:0051298 | centrosome duplication(GO:0051298) |
0.0 | 1.4 | GO:0048265 | response to pain(GO:0048265) |
0.0 | 0.3 | GO:1901910 | diadenosine polyphosphate catabolic process(GO:0015961) diphosphoinositol polyphosphate metabolic process(GO:0071543) diadenosine pentaphosphate metabolic process(GO:1901906) diadenosine pentaphosphate catabolic process(GO:1901907) diadenosine hexaphosphate metabolic process(GO:1901908) diadenosine hexaphosphate catabolic process(GO:1901909) adenosine 5'-(hexahydrogen pentaphosphate) metabolic process(GO:1901910) adenosine 5'-(hexahydrogen pentaphosphate) catabolic process(GO:1901911) |
0.0 | 0.2 | GO:0044417 | translocation of peptides or proteins into host(GO:0042000) translocation of peptides or proteins into host cell cytoplasm(GO:0044053) translocation of molecules into host(GO:0044417) translocation of peptides or proteins into other organism involved in symbiotic interaction(GO:0051808) translocation of molecules into other organism involved in symbiotic interaction(GO:0051836) |
0.0 | 0.2 | GO:0044537 | regulation of circulating fibrinogen levels(GO:0044537) |
0.0 | 0.3 | GO:0006574 | valine catabolic process(GO:0006574) |
0.0 | 0.4 | GO:0042989 | sequestering of actin monomers(GO:0042989) |
0.0 | 1.3 | GO:0003094 | glomerular filtration(GO:0003094) |
0.0 | 1.6 | GO:0006198 | cAMP catabolic process(GO:0006198) |
0.0 | 0.2 | GO:0043335 | protein unfolding(GO:0043335) |
0.0 | 0.1 | GO:0090080 | positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
0.0 | 0.3 | GO:0098914 | membrane repolarization during atrial cardiac muscle cell action potential(GO:0098914) |
0.0 | 2.0 | GO:0015949 | nucleobase-containing small molecule interconversion(GO:0015949) |
0.0 | 0.7 | GO:0046007 | negative regulation of activated T cell proliferation(GO:0046007) |
0.0 | 1.9 | GO:0019933 | cAMP-mediated signaling(GO:0019933) |
0.0 | 0.7 | GO:0035414 | negative regulation of catenin import into nucleus(GO:0035414) |
0.0 | 0.2 | GO:1902410 | mitotic cytokinetic process(GO:1902410) |
0.0 | 0.8 | GO:0061003 | positive regulation of dendritic spine morphogenesis(GO:0061003) |
0.0 | 0.6 | GO:0090102 | cochlea development(GO:0090102) |
0.0 | 0.1 | GO:0048294 | negative regulation of isotype switching to IgE isotypes(GO:0048294) |
0.0 | 0.9 | GO:1904776 | regulation of protein localization to cell cortex(GO:1904776) positive regulation of protein localization to cell cortex(GO:1904778) |
0.0 | 3.5 | GO:0042308 | negative regulation of protein import into nucleus(GO:0042308) negative regulation of protein import(GO:1904590) |
0.0 | 0.5 | GO:0007498 | mesoderm development(GO:0007498) |
0.0 | 0.3 | GO:0032962 | positive regulation of inositol trisphosphate biosynthetic process(GO:0032962) |
0.0 | 2.0 | GO:0015914 | phospholipid transport(GO:0015914) |
0.0 | 0.2 | GO:0070459 | prolactin secretion(GO:0070459) |
0.0 | 0.1 | GO:0061300 | cerebellum vasculature development(GO:0061300) |
0.0 | 2.7 | GO:0061178 | regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061178) |
0.0 | 1.5 | GO:0016339 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
0.0 | 0.5 | GO:0008088 | axo-dendritic transport(GO:0008088) |
0.0 | 1.0 | GO:0048012 | hepatocyte growth factor receptor signaling pathway(GO:0048012) |
0.0 | 0.2 | GO:0051684 | maintenance of Golgi location(GO:0051684) |
0.0 | 0.6 | GO:0060393 | pathway-restricted SMAD protein phosphorylation(GO:0060389) regulation of pathway-restricted SMAD protein phosphorylation(GO:0060393) |
0.0 | 0.4 | GO:0097240 | meiotic telomere tethering at nuclear periphery(GO:0044821) meiotic attachment of telomere to nuclear envelope(GO:0070197) chromosome attachment to the nuclear envelope(GO:0097240) |
0.0 | 1.7 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
0.0 | 2.6 | GO:0015701 | bicarbonate transport(GO:0015701) |
0.0 | 0.5 | GO:0006558 | L-phenylalanine metabolic process(GO:0006558) L-phenylalanine catabolic process(GO:0006559) erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process(GO:1902221) erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process(GO:1902222) |
0.0 | 0.8 | GO:0030516 | regulation of axon extension(GO:0030516) |
0.0 | 0.3 | GO:1900449 | regulation of glutamate receptor signaling pathway(GO:1900449) |
0.0 | 0.1 | GO:0003431 | growth plate cartilage chondrocyte development(GO:0003431) |
0.0 | 0.2 | GO:0032392 | DNA geometric change(GO:0032392) |
0.0 | 1.3 | GO:0042026 | protein refolding(GO:0042026) |
0.0 | 0.2 | GO:1903070 | negative regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903070) |
0.0 | 0.4 | GO:2000427 | positive regulation of apoptotic cell clearance(GO:2000427) |
0.0 | 0.3 | GO:0002043 | blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:0002043) |
0.0 | 0.1 | GO:0050882 | voluntary musculoskeletal movement(GO:0050882) |
0.0 | 0.9 | GO:0045880 | positive regulation of smoothened signaling pathway(GO:0045880) |
0.0 | 0.4 | GO:0010991 | negative regulation of SMAD protein complex assembly(GO:0010991) |
0.0 | 0.2 | GO:0042986 | positive regulation of amyloid precursor protein biosynthetic process(GO:0042986) |
0.0 | 0.7 | GO:0003338 | metanephros morphogenesis(GO:0003338) |
0.0 | 2.8 | GO:0030593 | neutrophil chemotaxis(GO:0030593) |
0.0 | 0.7 | GO:0070884 | regulation of calcineurin-NFAT signaling cascade(GO:0070884) |
0.0 | 0.4 | GO:0045008 | depyrimidination(GO:0045008) |
0.0 | 0.4 | GO:0016926 | protein desumoylation(GO:0016926) |
0.0 | 1.8 | GO:0035690 | cellular response to drug(GO:0035690) |
0.0 | 0.4 | GO:0043248 | proteasome assembly(GO:0043248) |
0.0 | 1.6 | GO:0006904 | vesicle docking involved in exocytosis(GO:0006904) |
0.0 | 0.1 | GO:0060394 | negative regulation of pathway-restricted SMAD protein phosphorylation(GO:0060394) |
0.0 | 1.1 | GO:0061512 | protein localization to cilium(GO:0061512) |
0.0 | 0.2 | GO:0050965 | detection of temperature stimulus involved in sensory perception(GO:0050961) detection of temperature stimulus involved in sensory perception of pain(GO:0050965) |
0.0 | 0.1 | GO:0060382 | regulation of DNA strand elongation(GO:0060382) |
0.0 | 3.8 | GO:1990830 | response to leukemia inhibitory factor(GO:1990823) cellular response to leukemia inhibitory factor(GO:1990830) |
0.0 | 3.9 | GO:0070268 | cornification(GO:0070268) |
0.0 | 0.2 | GO:0060836 | lymphatic endothelial cell differentiation(GO:0060836) |
0.0 | 0.3 | GO:0060384 | innervation(GO:0060384) |
0.0 | 0.6 | GO:0032288 | myelin assembly(GO:0032288) |
0.0 | 0.1 | GO:0000710 | meiotic mismatch repair(GO:0000710) |
0.0 | 0.2 | GO:0032836 | glomerular basement membrane development(GO:0032836) |
0.0 | 0.2 | GO:0045919 | positive regulation of cytolysis(GO:0045919) |
0.0 | 0.6 | GO:0030835 | negative regulation of actin filament depolymerization(GO:0030835) |
0.0 | 0.8 | GO:0050919 | negative chemotaxis(GO:0050919) |
0.0 | 0.8 | GO:0045494 | photoreceptor cell maintenance(GO:0045494) |
0.0 | 0.2 | GO:0006741 | NADP biosynthetic process(GO:0006741) |
0.0 | 0.1 | GO:0030042 | actin filament depolymerization(GO:0030042) |
0.0 | 1.5 | GO:0048384 | retinoic acid receptor signaling pathway(GO:0048384) |
0.0 | 0.2 | GO:1904381 | Golgi apparatus mannose trimming(GO:1904381) |
0.0 | 0.6 | GO:0031115 | negative regulation of microtubule polymerization(GO:0031115) |
0.0 | 0.4 | GO:0045601 | regulation of endothelial cell differentiation(GO:0045601) |
0.0 | 0.1 | GO:0009386 | translational attenuation(GO:0009386) |
0.0 | 0.6 | GO:1901522 | positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus(GO:1901522) |
0.0 | 1.7 | GO:1901379 | regulation of potassium ion transmembrane transport(GO:1901379) |
0.0 | 0.3 | GO:2001241 | positive regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001241) |
0.0 | 0.3 | GO:0010839 | negative regulation of keratinocyte proliferation(GO:0010839) |
0.0 | 0.8 | GO:0031102 | neuron projection regeneration(GO:0031102) |
0.0 | 0.1 | GO:0042262 | DNA protection(GO:0042262) |
0.0 | 0.4 | GO:0060074 | synapse maturation(GO:0060074) |
0.0 | 0.1 | GO:0038169 | somatostatin receptor signaling pathway(GO:0038169) somatostatin signaling pathway(GO:0038170) |
0.0 | 0.2 | GO:0032049 | cardiolipin biosynthetic process(GO:0032049) |
0.0 | 1.4 | GO:0038128 | ERBB2 signaling pathway(GO:0038128) |
0.0 | 0.2 | GO:0035725 | sodium ion transmembrane transport(GO:0035725) |
0.0 | 0.3 | GO:0006054 | N-acetylneuraminate metabolic process(GO:0006054) |
0.0 | 1.0 | GO:0000266 | mitochondrial fission(GO:0000266) |
0.0 | 0.1 | GO:0001952 | regulation of cell-matrix adhesion(GO:0001952) |
0.0 | 0.2 | GO:0010002 | cardioblast differentiation(GO:0010002) |
0.0 | 0.2 | GO:0035413 | positive regulation of catenin import into nucleus(GO:0035413) |
0.0 | 0.3 | GO:0008053 | mitochondrial fusion(GO:0008053) |
0.0 | 1.7 | GO:0001578 | microtubule bundle formation(GO:0001578) |
0.0 | 1.5 | GO:0006911 | phagocytosis, engulfment(GO:0006911) |
0.0 | 1.2 | GO:0035914 | skeletal muscle cell differentiation(GO:0035914) |
0.0 | 0.1 | GO:0001189 | RNA polymerase I transcriptional preinitiation complex assembly(GO:0001188) RNA polymerase I transcriptional preinitiation complex assembly at the promoter for the nuclear large rRNA transcript(GO:0001189) |
0.0 | 0.1 | GO:0002528 | regulation of vascular permeability involved in acute inflammatory response(GO:0002528) |
0.0 | 0.2 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
0.0 | 0.1 | GO:1902969 | mitotic DNA replication(GO:1902969) |
0.0 | 0.2 | GO:0030046 | parallel actin filament bundle assembly(GO:0030046) |
0.0 | 0.5 | GO:0060113 | inner ear receptor cell differentiation(GO:0060113) |
0.0 | 0.9 | GO:0080171 | lysosome organization(GO:0007040) lytic vacuole organization(GO:0080171) |
0.0 | 0.6 | GO:0006779 | porphyrin-containing compound biosynthetic process(GO:0006779) |
0.0 | 0.1 | GO:0060754 | regulation of mast cell chemotaxis(GO:0060753) positive regulation of mast cell chemotaxis(GO:0060754) |
0.0 | 1.7 | GO:0048024 | regulation of mRNA splicing, via spliceosome(GO:0048024) |
0.0 | 0.1 | GO:1904154 | positive regulation of retrograde protein transport, ER to cytosol(GO:1904154) |
0.0 | 0.2 | GO:1903025 | regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903025) |
0.0 | 0.1 | GO:1903078 | positive regulation of protein localization to plasma membrane(GO:1903078) positive regulation of protein localization to cell periphery(GO:1904377) |
0.0 | 0.1 | GO:0045116 | protein neddylation(GO:0045116) |
0.0 | 0.1 | GO:0006348 | chromatin silencing at telomere(GO:0006348) |
0.0 | 0.1 | GO:0052422 | modulation by symbiont of host molecular function(GO:0052055) modulation of catalytic activity in other organism involved in symbiotic interaction(GO:0052203) modulation by host of symbiont catalytic activity(GO:0052422) |
0.0 | 0.7 | GO:0051965 | positive regulation of synapse assembly(GO:0051965) |